Tetsuji Nishimura
Overview
Explore the profile of Tetsuji Nishimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishimura T
Yakugaku Zasshi
. 2023 Jul;
143(7):565-580.
PMID: 37394453
The research achievements in the field of regulatory science from the beginning of my research are described in an overview. First, I was interested in the complexity of development and...
2.
Yanagisawa Y, Isama K, Kurosu T, Natsume Y, Seino T, Nishimura T, et al.
J Pharm Health Care Sci
. 2022 Jun;
8(1):19.
PMID: 35706055
Background: In Japan, engineering controls for preparing injectable anticancer drugs are inadequate and compliance with appropriate preparation procedures is vital. In this study, we evaluated the effects of adherence to...
3.
Yanagisawa Y, Isama K, Kurosu T, Natsume Y, Seino T, Nishimura T, et al.
Yakugaku Zasshi
. 2022 Jun;
142(6):651-659.
PMID: 35650085
Many healthcare workers who handle anticancer drugs are at risk for occupational exposure. However, there are no established permissible limits for occupational exposure to anticancer drugs; thus, in this study,...
4.
Suzuki T, Kosugi Y, Watanabe K, Iida H, Nishimura T
Chem Pharm Bull (Tokyo)
. 2021 Sep;
69(9):840-853.
PMID: 34470948
Active pharmaceutical ingredients (APIs) have become a public concern owing to their possible adverse effects on aquatic organisms. Ministry of Health, Labor and Welfare in Japan (MHLW) issued "Guidance on...
5.
Fujitani T, Inomata A, Ogata A, Sakamoto Y, Hirose A, Nishimura T, et al.
Toxicol Rep
. 2017 Oct;
2:1404-1408.
PMID: 28962481
The fetal toxicities of multi-wall carbon nanotubes (MWCNTs) with various sizes were compared in CD1(ICR) mice. MWCNTs were suspended in 2% sodium carboxymethyl cellulose solution in phosphate-buffered saline. On day...
6.
Shimizu K, Kubota R, Kobayashi N, Tahara M, Sugimoto N, Nishimura T, et al.
Materials (Basel)
. 2017 Aug;
6(7):2713-2722.
PMID: 28811404
Fullerenes C have attracted considerable attention in the biomedical field due to their interesting properties. Although there has been a concern that C could be metabolized to hydroxylated fullerenes (C(OH))...
7.
Isoda K, Nagata R, Hasegawa T, Taira Y, Taira I, Shimizu Y, et al.
Nanoscale Res Lett
. 2017 Mar;
12(1):199.
PMID: 28314361
Nanomaterials are relatively new and unconventional materials with many useful properties, but their effects on biological systems are poorly understood. Nanoclay is a general term for layered mineral silicate nanoparticles...
8.
Yasui M, Kamoshita N, Nishimura T, Honma M
Genes Environ
. 2016 Jun;
37:6.
PMID: 27350803
Introduction: Asbestos-induced formation of mesothelioma has been attributed to phenotypic and morphological changes in cells caused by polyploidization and aneuploidization, and multiwalled carbon nanotubes (MWCNTs) are suspected to have similar...
9.
Watanabe H, Tamura I, Abe R, Takanobu H, Nakamura A, Suzuki T, et al.
Environ Toxicol Chem
. 2015 Oct;
35(4):996-1006.
PMID: 26472177
Principles of concentration addition and independent action have been used as effective tools to predict mixture toxicity based on individual component toxicity. The authors investigated the toxicity of a pharmaceutical...
10.
Simazaki D, Kubota R, Suzuki T, Akiba M, Nishimura T, Kunikane S
Water Res
. 2015 Apr;
76:187-200.
PMID: 25835589
The present study was performed to determine the occurrence of 64 pharmaceuticals and metabolites in source water and finished water at 6 drinking water purification plants and 2 industrial water...